SMARCA2 and cancer: As Brg1/Brm loss changes the gene expression profiles to favor cancer development in conjunction with the effects that Brg1 and Brm loss appears to exert on Rb and p53 function, we would expect that the loss of Brg1 and/or Brm would hasten tumor development.